.

Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Dow
US Department of Justice
Argus Health
Harvard Business School
QuintilesIMS
Healthtrust
Covington
UBS
AstraZeneca
Cipla

Generated: December 13, 2017

DrugPatentWatch Database Preview

Penem Antibacterial Drug-Class List

« Back to Dashboard

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Patent Submitted Product Substance Delist Req. Exclusivity Expiration
Rempex Pharms MedcnsVABOMEREmeropenem; vaborbactamPOWDER;IV (INFUSION)209776-001Aug 29, 2017RXYesYes► Subscribe► Subscribe► SubscribeYY► Subscribe
Rempex Pharms MedcnsVABOMEREmeropenem; vaborbactamPOWDER;IV (INFUSION)209776-001Aug 29, 2017RXYesYes► Subscribe► Subscribe► Subscribe► Subscribe
MerckPRIMAXINcilastatin sodium; imipenemPOWDER;INTRAVENOUS050587-001Nov 26, 1985APRXYesYes► Subscribe► Subscribe► Subscribe► Subscribe
MerckPRIMAXINcilastatin sodium; imipenemPOWDER;INTRAVENOUS050587-002Nov 26, 1985APRXYesYes► Subscribe► Subscribe► Subscribe► Subscribe
MerckPRIMAXINcilastatin sodium; imipenemINJECTABLE;INJECTION062756-001Jan 8, 1987DISCNNoNo► Subscribe► Subscribe► Subscribe► Subscribe
MerckPRIMAXINcilastatin sodium; imipenemINJECTABLE;INJECTION062756-002Jan 8, 1987DISCNNoNo► Subscribe► Subscribe► Subscribe► Subscribe
PfizerMERREMmeropenemINJECTABLE;INJECTION050706-001Jun 21, 1996APRXYesYes► Subscribe► Subscribe► Subscribe► Subscribe
PfizerMERREMmeropenemINJECTABLE;INJECTION050706-003Jun 21, 1996APRXYesYes► Subscribe► Subscribe► Subscribe► Subscribe
B Braun Medical IncMEROPENEM AND SODIUM CHLORIDE IN DUPLEX CONTAINERmeropenemPOWDER;IV (INFUSION)202106-002Apr 30, 2015RXNoNo► Subscribe► Subscribe► Subscribe► Subscribe
B Braun Medical IncMEROPENEM AND SODIUM CHLORIDE IN DUPLEX CONTAINERmeropenemPOWDER;IV (INFUSION)202106-001Apr 30, 2015RXNoNo► Subscribe► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

US Army
QuintilesIMS
Covington
Cipla
Fuji
Moodys
McKesson
Healthtrust
McKinsey
Harvard Business School

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot